These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8030847)

  • 41. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.
    de Bruijn IA; Remarque EJ; Jol-van der Zijde CM; van Tol MJ; Westendorp RG; Knook DL
    J Infect Dis; 1999 Jan; 179(1):31-6. PubMed ID: 9841819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly.
    Bosch M; Méndez M; Pérez M; Farran A; Fuentes MC; Cuñé J
    Nutr Hosp; 2012; 27(2):504-9. PubMed ID: 22732975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody responses to influenza virus subunit vaccine in the aged.
    Feery BJ; Evered MG; Morrison EI
    Med J Aust; 1976 Apr; 1(15):540, 542. PubMed ID: 933946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.
    van den Berg SPH; Wong A; Hendriks M; Jacobi RHJ; van Baarle D; van Beek J
    Front Immunol; 2018; 9():82. PubMed ID: 29434600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of an adjuvant to enhance the immune response to influenza vaccine in the elderly.
    Martin JT
    Biologicals; 1997 Jun; 25(2):209-13. PubMed ID: 9236054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evidence and guidelines for influenza and pneumococcal vaccines for the elderly].
    Gerstoft J; Helleberg M
    Ugeskr Laeger; 2013 Nov; 175(47):2861-4. PubMed ID: 24629386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM; Neri M; Lepri E; Camilloni B; Basileo M; Sigismondi N; Fabiani C; Calzoletti L; Puzelli S; Donatelli I
    Vaccine; 2006 Nov; 24(44-46):6615-9. PubMed ID: 16828941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a Taiji and Qigong intervention on the antibody response to influenza vaccine in older adults.
    Yang Y; Verkuilen J; Rosengren KS; Mariani RA; Reed M; Grubisich SA; Woods JA
    Am J Chin Med; 2007; 35(4):597-607. PubMed ID: 17708626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased antibody response to influenza vaccine among nursing-home residents who received recalled vaccine--New York, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Dec; 45(50):1100-2. PubMed ID: 8999309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women.
    Huang YP; Pechere JC; Michel M; Gauthey L; Loreto M; Curran JA; Michel JP
    J Immunol; 1992 Feb; 148(3):715-22. PubMed ID: 1730868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine.
    Carle F; Bolgiani M; Zanon P; Moiraghi Ruggenini A; Zotti C
    Boll Ist Sieroter Milan; 1988; 67(2):105-15. PubMed ID: 3067735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly.
    Arden NH; Patriarca PA; Lui KJ; Harmon MW; Brandon F; Kendal AP
    J Infect Dis; 1986 Apr; 153(4):805-6. PubMed ID: 3950454
    [No Abstract]   [Full Text] [Related]  

  • 53. [Efficacy of influenza vaccine in institutionalized patients].
    Rodríguez Alonso M; García Manso M; Negro González E
    Aten Primaria; 2000 May; 25(9):664-5. PubMed ID: 10920526
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of sleep deprivation on response to immunization.
    Spiegel K; Sheridan JF; Van Cauter E
    JAMA; 2002 Sep; 288(12):1471-2. PubMed ID: 12243633
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaccines for preventing influenza in the elderly.
    Demicheli V; Jefferson T; Di Pietrantonj C; Ferroni E; Thorning S; Thomas RE; Rivetti A
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004876. PubMed ID: 29388197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influenza vaccination in the elderly: impact on hospitalisation and mortality.
    Nichol KL
    Drugs Aging; 2005; 22(6):495-515. PubMed ID: 15974640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impaired antibody response to influenza vaccine in institutionalized elderly.
    Provinciali M; Di Stefano G; Muzzioli M; Scarpazza P; Colombo D; Migliorino M; Bellani M; Colombo M; Della Croce F; Gandolfi MC
    Ann N Y Acad Sci; 1994 Jun; 717():307-14. PubMed ID: 8030847
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibody response to 1995-1996 influenza vaccine in institutionalized and non-institutionalized elderly women.
    Iorio AM; Alatri A; Camilloni B; Neri M; Baglio G; Donatelli I
    Gerontology; 1999; 45(1):31-8. PubMed ID: 9852378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.
    Van Hoecke C; Prikazsky V; Utö I; Menschikowski C
    Gerontology; 1996; 42(4):190-8. PubMed ID: 8832266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
    Nunzi E; Iorio AM; Camilloni B
    Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.